These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 20211100

  • 1. Role of concurrent chemoradiation in laryngeal preservation for supraglottic cancer.
    Yoon TM, Lee JK, Cho JS, Lim SC, Chung WK.
    J Otolaryngol Head Neck Surg; 2010 Apr; 39(2):142-9. PubMed ID: 20211100
    [Abstract] [Full Text] [Related]

  • 2. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J, Liao Z, Zhang Z, Ajani J, Swisher S, Chang JY, Jeter M, Guerrero T, Stevens CW, Vaporciyan A, Putnam J, Walsh G, Smythe R, Roth J, Yao J, Allen P, Cox JD, Komaki R.
    Int J Radiat Oncol Biol Phys; 2004 Oct 01; 60(2):427-36. PubMed ID: 15380576
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Does induction chemotherapy still have a role in larynx preservation strategies? The experience of Institut Catala d'Oncologia in stage III larynx carcinoma.
    Majem M, Mesia R, Mañós M, Gomez J, Galiana R, Cardenal F, Juan A, Montes A, Perez FJ, Nogues J, Llluch JR.
    Laryngoscope; 2006 Sep 01; 116(9):1651-6. PubMed ID: 16954998
    [Abstract] [Full Text] [Related]

  • 8. Chemoradiotherapy laryngeal preservation for advanced hypopharyngeal cancer.
    Tai SK, Yang MH, Wang LW, Tsai TL, Chu PY, Wang YF, Huang JL, Chang SY.
    Jpn J Clin Oncol; 2008 Aug 01; 38(8):521-7. PubMed ID: 18697758
    [Abstract] [Full Text] [Related]

  • 9. Treatment outcomes for radiotherapy alone are comparable with neoadjuvant chemotherapy followed by radiotherapy in early-stage nasopharyngeal carcinoma.
    Song CH, Wu HG, Heo DS, Kim KH, Sung MW, Park CI.
    Laryngoscope; 2008 Apr 01; 118(4):663-70. PubMed ID: 18216741
    [Abstract] [Full Text] [Related]

  • 10. Induction chemotherapy followed by either chemoradiotherapy or bioradiotherapy for larynx preservation: the TREMPLIN randomized phase II study.
    Lefebvre JL, Pointreau Y, Rolland F, Alfonsi M, Baudoux A, Sire C, de Raucourt D, Malard O, Degardin M, Tuchais C, Blot E, Rives M, Reyt E, Tourani JM, Geoffrois L, Peyrade F, Guichard F, Chevalier D, Babin E, Lang P, Janot F, Calais G, Garaud P, Bardet E.
    J Clin Oncol; 2013 Mar 01; 31(7):853-9. PubMed ID: 23341517
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Induction chemotherapy and larynx preservation: is such practice useful?].
    Sarini J, Bocciolini C, Fournier C, Penel N, Kara A, Van JT, Lefebvre JL.
    Bull Cancer; 2002 Apr 01; 89(4):411-7. PubMed ID: 12016041
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Concurrent chemoradiotherapy versus radiotherapy in advanced cervical carcinoma].
    Zeng SY, Li LY, Shu KY, Pan M, Li HP, Luo B.
    Ai Zheng; 2008 Sep 01; 27(9):942-6. PubMed ID: 18799032
    [Abstract] [Full Text] [Related]

  • 15. High-dose cisplatin as neoadjuvant organ-preserving chemotherapy for squamous cell carcinoma of the larynx.
    Lacava JA, Ferreyra R, Leone BA, Losada C, Elem YL, Vallejo CT.
    Cancer J Sci Am; 1996 Sep 01; 2(1):46-51. PubMed ID: 9166498
    [Abstract] [Full Text] [Related]

  • 16. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
    Liao Z, Zhang Z, Jin J, Ajani JA, Swisher SG, Stevens CW, Ho L, Smythe R, Vaporciyan AA, Putnam JB, Walsh GL, Roth JA, Yao JC, Allen PK, Cox JD, Komaki R.
    Int J Radiat Oncol Biol Phys; 2004 Dec 01; 60(5):1484-93. PubMed ID: 15590179
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Concurrent chemoradiotherapy for T4 patients with hypopharyngeal and laryngeal squamous cell carcinomas.
    Nishimura G, Tsukuda M, Horiuchi C, Satake K, Yoshida T, Nagao J, Kawakami M, Kondo N, Arai Y, Taguchi T, Matsuda H, Mikami Y.
    Auris Nasus Larynx; 2007 Dec 01; 34(4):499-504. PubMed ID: 17604583
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Concurrent chemoradiotherapy with cisplatin, 5-fluorouracil, methotrexate, and leucovorin in patients with advanced resectable squamous cell carcinoma of the larynx and hypopharynx.
    Taguchi T, Tsukuda M, Mikami Y, Matsuda H, Horiuchi C, Yoshida T, Nishimura G, Ishitoya J, Katori H.
    Acta Otolaryngol; 2006 Apr 01; 126(4):408-13. PubMed ID: 16608794
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.